Remove authors merit
article thumbnail

Pfizer -Walk-In Drive For Multiple Openings On 11th & 12th March 2023

Pharma Pathway

Authoring and/or contributing line to Clinical/ Nonclinical/ CMC content for DMFs/ INDs/ IMPDs/ NDAs/ ANDAs/ MAAs/ Post approval variations/ Supplements for Global markets.

article thumbnail

FDA makes moves to advance ALS research ahead of upcoming Amylyx AdCom

Pharmaceutical Technology

Dr Merit Cudkowicz, a co-principal investigator in Amylyx’s clinical trials, says patients and investigators are pushing for an approval given the unmet need for therapies. “By The Act authorizes the appropriation of $100,000,000 per fiscal year from 2022 to 2026.

FDA 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The key to succeeding at population health analytics

Clarify Health

Martha Sylvia, PhD, MBA, RN, Associate Professor, Medical University of South Carolina College of Nursing and President, ForestVue Healthcare Solutions, co-authored “Population Health Analytics,” a “how-to-guide” that prepares the healthcare workforce on using population health management software to improve health outcomes.

article thumbnail

The key to succeeding at population health analytics

Clarify Health

Martha Sylvia, PhD, MBA, RN, Associate Professor, Medical University of South Carolina College of Nursing and President, ForestVue Healthcare Solutions, co-authored “Population Health Analytics,” a “how-to-guide” that prepares the healthcare workforce on using population health management software to improve health outcomes.

article thumbnail

The EU HTA regulation: a new frontier for access to innovative technologies

European Pharmaceutical Review

based process (HTA) that will allow the competent EU and national authorities to determine the effectiveness of new or existing health technologies (eg, medicinal products, medical devices, in vitro diagnostic medical devices, medical procedures and measures to prevent, diagnose or treat diseases). About the authors.

article thumbnail

Why reshoring drug production means embracing continuous manufacturing

pharmaphorum

It’s the merits that are relevant here. About the author. Unlike batch manufacturing, where drug production is segmented into a series of slow-moving steps, continuous manufacturing relies on a fully integrated process that runs uninterrupted from beginning to end. The case for inshoring is clear.

article thumbnail

Treating Alzheimer’s: regulatory hurdles in an anti-amyloid revolution

European Pharmaceutical Review

About the author Gareth Morgan is a life sciences partner at multinational law firm Pinsent Masons. EMA Deciding If Donanemab For Alzheimer’s & Three Other Drugs Merit Fast-Tracking. This would be a welcome boost for Alzheimer’s sufferers in Europe. Available from: [link] Sims J, Zimmer J, Evans C , et al. cited 2023Aug].